Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

View:
Post by woundedknee on Nov 01, 2021 1:59pm

I can understand

I can understand longs hanging on to this and even having some optimism about the future. This will be another year before a phase three do-over, if I may use that term. I will never buy this stock considering the present leadership. I would buy if Dan stepped down, but only a small amount. I hope for the sake of those in the red that the stock goes back to 5 bucks, but it's too big a risk for me and for now it remains on my watch list. gl
Comment by baggerx99 on Nov 01, 2021 3:01pm
Leadership is doing just fine managing the progress,  all of which is regulated by various health bodies to get to finish line to final FDA approval.....whether its Dan or whoever same results would have played out.......
Comment by Daydream2 on Nov 01, 2021 3:53pm
More than ever, this would be the time for management to buy into the stock. That would be leadership.
Comment by woundedknee on Nov 02, 2021 7:14am
I agree, the same results would have played out as you say. My message goes deeper than that.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities